Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.790
-0.030 (-1.06%)
At close: Sep 17, 2026, 4:00 PM EDT
2.800
+0.010 (0.36%)
After-hours: Sep 17, 2026, 7:30 PM EDT
Boundless Bio Employees
Boundless Bio had 28 employees as of December 31, 2025. The number of employees decreased by 36 or -56.25% compared to the previous year.
Employees
28
Change (1Y)
-36
Growth (1Y)
-56.25%
Revenue / Employee
n/a
Profits / Employee
-$2,286,143
Market Cap
63.69M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | -36 | -56.25% |
| Dec 31, 2024 | 64 | -8 | -11.11% |
| Mar 31, 2024 | 72 | 0 | - |
| Dec 31, 2023 | 72 | - | - |
| Sep 30, 2023 | 71 | - | - |
| Jun 30, 2023 | 72 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Gossamer Bio | 162 |
| Heron Therapeutics | 128 |
| Alps Group | 93 |
| XBiotech | 87 |
| Spero Therapeutics | 25 |
| INmune Bio | 21 |
| LeonaBio | 19 |
BOLD News
- 2 days ago - Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Names Senior Leadership Team to Advance Potential Best-in-Class in vivo Base Editing Program for Alpha-1 Antitrypsin Deficiency - GlobeNewsWire
- 8 days ago - Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer - GlobeNewsWire
- 5 weeks ago - Boundless Bio Quarterly report: Q2 2026 - Filings
- 2 months ago - Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their Shareholders - GlobeNewsWire
- 2 months ago - Boundless Bio, Serapha Bio to combine in all-stock merger - TheFly
- 2 months ago - Boundless Bio Transcript: M&A announcement - Transcripts
- 2 months ago - Boundless Bio Press release: M&A announcement - Filings
- 2 months ago - Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement - GlobeNewsWire